New program aims to help cancer survivors kick the habit and ease pain
NCT ID NCT06029907
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study tested a program to help cancer survivors quit smoking and manage pain. Nineteen survivors received counseling and the medication varenicline (Chantix). The goal was to see if the program was practical and helpful, not yet to prove it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- varenicline (Chantix)
- What this could lead to
- If successful, this program could offer a practical way to help cancer survivors quit smoking and manage pain at the same time.
- What could go wrong
- This is a very small pilot study with only 19 participants, so results may not apply to all survivors. The program's effectiveness is still uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University Health System
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Electric pulses on the wrist may tame colonoscopy pain
- Can a Two-Drug combo break the smoking habit?
- Virtual reality may distract patients from pain and fear during anesthesia
- Personalized nicotine patch dosing may boost quit rates